Efficient Targeting of T Cell Malignancies In Vitro and In Vivo Using CD4-Specific Chimeric Antigen Receptor (CAR)-Engineered NK Cells

被引：0
|
作者：
Pinz, Kevin G. [1 ]
Yakaboski, Elizabeth [1 ]
Jares, Alexander [2 ]
Liu, Hua [2 ]
Firor, Amelia E. [1 ]
Wada, Masayuki [1 ]
Leung, Lai-Han [3 ]
Jiang, Xun [1 ]
Ma, Yupo [2 ]
机构：
[1] ICell Gene Therapeut LLC, Stony Brook, NY USA
[2] Stony Brook Med, Pathol, Stony Brook, NY USA
[3] Macau Univ Sci & Technol, Inst Appl Res Med, Macau, Peoples R China
来源：
MOLECULAR THERAPY | 2016年 / 24卷
关键词：
D O I：
10.1016/S1525-0016(16)33455-4
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
647
引用
收藏
页码：S256 / S257
页数：2
相关论文
共 50 条
  • [21] Assaying fibroblast activation protein (FAP) expression in vivo and in vitro for possible targeting with chimeric antigen receptor (CAR) T cells
    Fernandez, Pedro O. Mendez
    Rurik, Joel G.
    Aghajanian, Haig
    Epstein, Jonathan A.
    FASEB JOURNAL, 2022, 36
  • [22] Chimeric Antigen Receptor (CAR) T-Cell Therapy for Thoracic Malignancies
    Kiesgen, Stefan
    Chicaybam, Leonardo
    Chintala, Navin K.
    Adusumilli, Prasad S.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (01) : 16 - 26
  • [23] Chimeric Antigen Receptor (CAR) T Cells Targeting the CD19 Antigen for the Treatment of Pediatric Relapsed B Cell ALL
    Curran, Kevin J.
    Riviere, Isabelle
    Kobos, Rachel
    Kernan, Nancy A.
    Boulad, Farid
    Prockop, Susan E.
    Scaradavou, Andromachi
    Renaud, Thomas M.
    Shukla, Neerav
    Steinherz, Peter G.
    Park, Jae H.
    Sauter, Craig S.
    O'Reilly, Richard J.
    Sadelain, Michel
    Brentjens, Renier J.
    BLOOD, 2014, 124 (21)
  • [24] Preclinical targeting of aggressive T-cell malignancies using anti-CD5 chimeric antigen receptor
    Chen, K. H.
    Wada, M.
    Pinz, K. G.
    Liu, H.
    Lin, K-W
    Jares, A.
    Firor, A. E.
    Shuai, X.
    Salman, H.
    Golightly, M.
    Lan, F.
    Senzel, L.
    Leung, E. L.
    Jiang, X.
    Ma, Y.
    LEUKEMIA, 2017, 31 (10) : 2151 - 2160
  • [25] Preclinical targeting of aggressive T-cell malignancies using anti-CD5 chimeric antigen receptor
    K H Chen
    M Wada
    K G Pinz
    H Liu
    K-W Lin
    A Jares
    A E Firor
    X Shuai
    H Salman
    M Golightly
    F Lan
    L Senzel
    E L Leung
    X Jiang
    Y Ma
    Leukemia, 2017, 31 : 2151 - 2160
  • [26] Efficient Generation of Murine Chimeric Antigen Receptor (CAR)-T Cells
    Vincent, Rosa L.
    Li, Fangda
    Ballister, Edward R.
    Arpaia, Nicholas
    Danino, Tal
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2024, (204):
  • [27] Novel anti-CD3 chimeric antigen receptor targeting of aggressive T cell malignancies
    Chen, Kevin H.
    Wada, Masayuki
    Firor, Amelia E.
    Pinz, Kevin G.
    Jares, Alexander
    Liu, Hua
    Salman, Huda
    Golightly, Marc
    Lan, Fengshuo
    Jiang, Xun
    Ma, Yupo
    ONCOTARGET, 2016, 7 (35) : 56219 - 56232
  • [28] GENETICALLY ENGINEERED INDUCED PLURIPOTENT STEM CELLS (IPSC) FOR THE EFFICIENT GENERATION OF HYPOIMMUNOGENEIC CHIMERIC ANTIGEN RECEPTOR (CAR)-ENGINEERED T CELLS
    Nianias, Alexandros
    Katsarou, Afroditi
    Prins, Henk-Jan
    Shahrabi, Aida
    van Velzen, Cindy
    Groen, Richard
    Mutis, Tuna
    Themeli, Maria
    EXPERIMENTAL HEMATOLOGY, 2022, 111 : S118 - S118
  • [29] Targeting gastrointestinal cancers with chimeric antigen receptor (CAR)-T cell therapy
    Staudt, Ross E.
    Carlson, Robert D.
    Snook, Adam E.
    CANCER BIOLOGY & THERAPY, 2022, 23 (01) : 127 - 133
  • [30] Targeting Cancer Stem Cells by Genetically Engineered Chimeric Antigen Receptor T Cells
    Alhabbab, Rowa Y.
    FRONTIERS IN GENETICS, 2020, 11
12345